Sangamo Therapeutics, Inc.
US ˙ NasdaqCM ˙ US8006771062

SecuritySGMO / Sangamo Therapeutics, Inc.
InsiderWilloughby Scott B.
This page shows the track record and history of Willoughby Scott B. insider trades in Sangamo Therapeutics, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Willoughby Scott B. in SGMO / Sangamo Therapeutics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

SGMO / Sangamo Therapeutics, Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Willoughby Scott B. in SGMO / Sangamo Therapeutics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

SGMO / Sangamo Therapeutics, Inc. Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2025-08-26 2025-08-24 4 Willoughby Scott B. SGMO Common Stock F - Taxes D 0.5863 -1,434 -1 748,243
2025-07-24 2025-07-22 4 Willoughby Scott B. SGMO Common Stock F - Taxes D 0.4798 -31,866 -15 749,677
2025-05-28 2025-05-24 4 Willoughby Scott B. SGMO Common Stock F - Taxes D 0.4733 -1,433 -1 781,543
2025-04-24 2025-04-22 4 Willoughby Scott B. SGMO Common Stock F - Taxes D 0.7763 -31,866 -25 782,976
2025-02-26 2025-02-25 4 Willoughby Scott B. SGMO Common Stock A - Award D 120,000 814,842
2025-02-26 2025-02-25 4 Willoughby Scott B. SGMO Common Stock F - Taxes D 0.9561 -1,375 -1 694,842
2025-02-26 2025-02-24 4 Willoughby Scott B. SGMO Common Stock F - Taxes D 1.0000 -1,434 -1 696,217
2025-01-24 2025-01-22 4 Willoughby Scott B. SGMO Common Stock F - Taxes D 1.1500 -129,549 -149 697,651
2024-11-26 2024-11-25 4 Willoughby Scott B. SGMO Common Stock F - Taxes D 1.9400 -1,371 -3 827,200
2024-11-26 2024-11-24 4 Willoughby Scott B. SGMO Common Stock F - Taxes D 1.8800 -1,430 -3 828,571
2024-08-27 2024-08-25 4 Willoughby Scott B. SGMO Common Stock F - Taxes D 0.8600 -1,371 -1 830,001
2024-08-27 2024-08-24 4 Willoughby Scott B. SGMO Common Stock F - Taxes D 0.8600 -1,430 -1 831,372
2024-08-15 2024-08-13 4 Willoughby Scott B. SGMO Common Stock F - Taxes D 0.9751 -892 -1 832,802
2024-05-29 2024-05-25 4 Willoughby Scott B. SGMO Common Stock F - Taxes D 0.6000 -1,336 -1 833,694
2024-05-29 2024-05-24 4 Willoughby Scott B. SGMO Common Stock F - Taxes D 0.6000 -1,400 -1 835,030
2024-02-27 2024-02-25 4 Willoughby Scott B. SGMO Common Stock F - Taxes D 1.1300 -3,453 -4 836,430
2024-02-27 2024-02-24 4 Willoughby Scott B. SGMO Common Stock F - Taxes D 1.1300 -4,379 -5 839,883
2024-01-24 2024-01-22 4 Willoughby Scott B. SGMO Common Stock A - Award D 712,500 844,262
2023-11-28 2023-11-25 4 Willoughby Scott B. SGMO Common Stock F - Taxes D 0.3821 -1,329 -1 126,762
2023-08-29 2023-08-25 4 Willoughby Scott B. SGMO Common Stock F - Taxes D 0.7700 -1,329 -1 128,091
2023-08-15 2023-08-13 4 Willoughby Scott B. SGMO Common Stock F - Taxes D 1.0800 -864 -1 129,420
2023-05-30 2023-05-25 4 Willoughby Scott B. SGMO Common Stock F - Taxes D 1.3300 -1,328 -2 125,284
2023-04-26 2023-04-24 4 Willoughby Scott B. SGMO Common Stock F - Taxes D 1.6500 -3,977 -7 126,612
2023-03-06 2023-02-25 4 Willoughby Scott B. SGMO Common Stock F - Taxes D 2.6600 -5,128 -14 130,589
2023-03-06 2023-02-24 4 Willoughby Scott B. SGMO Common Stock A - Award D 42,750 135,717
2022-08-16 2022-08-13 4 Willoughby Scott B. SGMO Common Stock F - Taxes D 6.3300 -864 -5 92,966
2022-05-03 2022-04-29 4 Willoughby Scott B. SGMO Common Stock F - Taxes D 4.1500 -140 -1 90,709
2022-04-26 2022-04-24 4 Willoughby Scott B. SGMO Common Stock F - Taxes D 4.7000 -3,976 -19 90,849
2022-03-01 2022-02-25 4 Willoughby Scott B. SGMO Stock Option (Right to Buy) A - Award D 5.90 110,700 110,700
2022-03-01 2022-02-25 4 Willoughby Scott B. SGMO Common Stock A - Award D 41,000 94,825
2022-03-01 2022-02-25 4 Willoughby Scott B. SGMO Common Stock F - Taxes D 5.9000 -1,566 -9 53,825
2021-11-03 2021-10-29 4 Willoughby Scott B. SGMO Common Stock F - Taxes D 8.1200 -140 -1 54,455
2021-08-17 2021-08-13 4 Willoughby Scott B. SGMO Stock Option (Right to Buy) A - Award D 10.05 15,000 15,000
2021-08-17 2021-08-13 4 Willoughby Scott B. SGMO Common Stock A - Award D 7,500 54,595
2021-08-09 3 Willoughby Scott B. SGMO Common Stock D 47,095
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)